Department of Paediatrics, Oslo University Hospital, Oslo, Norway.
Allergy. 2010 Sep;65(9):1134-40. doi: 10.1111/j.1398-9995.2010.02344.x. Epub 2010 Mar 5.
Allergic sensitisation increases the risk for asthma development. In this prospective birth cohort (Environment and Childhood Asthma) study, we hypothesized that combining quantitative measures of IgE antibodies (Sigma-IgE) and Severity score of obstructive airways disease (OAD) at 2 years of age (Severity score) is superior to predict current asthma (CA) at 10 years than either measure alone. Secondarily, we assessed if gender modified the prediction of CA.
A follow-up study at 10 years of age was performed in 371 2-year-old children with recurrent (n = 219) or no (n = 152) bronchial obstruction with available serum analysed for Sigma-IgE to common food and inhalant allergens through a panel test, Phadiatop Infant) (Phadia, Uppsala, Sweden). Clinical variables included allergic sensitisation and exercise testing to characterise children with CA vs not CA at 10 years and the Severity score (0-12, 0 indicating no OAD) was used to assess risk modification.
Severity score alone explained 24% (Nagelkerke R(2) = 0.24) of the variation in CA, whereas Sigma-IgE explained only 6% (R(2) = 0.06). Combining the two increased the explanatory capacity to R(2) = 0.30. Gender interacted significantly with Sigma-IgE; whereas Severity score predicted CA in both genders, the predictive capacity of Sigma-IgE for CA at 10 years was significant in boys only.
Combining Sigma-IgE to inhalant allergens and Severity score at 2 years was superior to predict asthma at 10 years than either alone. Severity score predicted CA in both genders, whereas Sigma-IgE significantly predicted CA in boys only.
过敏致敏会增加哮喘发展的风险。在这项前瞻性出生队列(环境与儿童哮喘)研究中,我们假设在 2 岁时结合定量 IgE 抗体(Sigma-IgE)测量和阻塞性气道疾病(OAD)严重程度评分(严重程度评分)比单独使用任何一种测量方法更能预测 10 岁时的当前哮喘(CA)。其次,我们评估了性别是否改变了 CA 的预测。
在 371 名 2 岁时出现反复(n=219)或无(n=152)支气管阻塞且有可用血清的儿童中进行了 10 岁时的随访研究,通过 panel 测试(Phadiatop Infant)(Phadia,Uppsala,瑞典)分析血清中 Sigma-IgE 对常见食物和吸入性过敏原的反应。临床变量包括过敏致敏和运动测试,以表征 10 岁时患有 CA 和未患有 CA 的儿童,并用严重程度评分(0-12,0 表示无 OAD)来评估风险修饰。
严重程度评分单独解释了 CA 变化的 24%(Nagelkerke R²=0.24),而 Sigma-IgE 仅解释了 6%(R²=0.06)。将两者结合起来,解释能力增加到 R²=0.30。性别与 Sigma-IgE 显著相互作用;尽管严重程度评分可预测男女两性的 CA,但 Sigma-IgE 对男孩 CA 的预测能力在统计学上显著。
在 2 岁时结合吸入性过敏原和严重程度评分的 Sigma-IgE 比单独使用任何一种方法更能预测 10 岁时的哮喘。严重程度评分可预测男女两性的 CA,而 Sigma-IgE 仅显著预测男孩的 CA。